Galina Marder is a Rheumatology/Immunology physician affiliated with Northwell Health. OpenAlex indexes 51 publications with 1,300 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2800 Marcus Ave
New Hyde Park, NY 110421008
Telephone
516-708-2550Registry record last updated 21 Jun 2013.
Clinical trials
- Belimumab in Idiopathic Inflammatory Myositis
Sponsor: Northwell Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20259 payments
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
21%SNRI9%Duloxetine Hcl100%Part D≥41 patientsGabapentinoids7.3%Gabapentin73%Pregabalin27%Part D<11 patients+ 3 more classes in this area
Dermatology
20.2%Corticosteroid20.2%Methylprednisolone sodium succinate95%Methylprednisolone6%Part D + Part B<11 patientsMetabolism & gastrointestinal
17.6%Corticosteroid15.1%Prednisone100%Part D≥63 patientsProton pump inhibitor2.6%Pantoprazole Sodium61%Omeprazole39%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Elana Koss, MD
Northwell Health
Peter Gregersen
Northwell Health
Frank Schwab, MD
Northwell Health
Louis Kavoussi, MD
Northwell Health
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”